Registered medicines are now available to acquire separate approval as orphan drug

Published: 2017-09-18 13:58:20

Updated: 2017-09-18 13:58:20

In order to promote manufacturing of orphan drugs, a system will be improved for already registered medicines to acquire separate product approval as am orphan drug.

The Minister of Food and Drug Safety(Minister Young-Jin Ryu, MFDS) gave an administrative notice of the ‘Partial Revision Bill to Regulations of Medicine Approval, Registration and Evaluation’ containing the contents above on the ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.